

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of amino acid transport (GO:0051956) | 6.77275852 |
| 2 | positive regulation of amino acid transport (GO:0051957) | 6.24232512 |
| 3 | phospholipid scrambling (GO:0017121) | 5.92861231 |
| 4 | negative regulation of neurotransmitter secretion (GO:0046929) | 5.82084730 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.72158272 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 5.72158272 |
| 7 | regulation of glutamate secretion (GO:0014048) | 5.48057513 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.47496943 |
| 9 | L-phenylalanine metabolic process (GO:0006558) | 5.47496943 |
| 10 | mannose metabolic process (GO:0006013) | 5.28743967 |
| 11 | aromatic amino acid family catabolic process (GO:0009074) | 5.27745400 |
| 12 | positive regulation of catecholamine secretion (GO:0033605) | 5.00091510 |
| 13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.93313666 |
| 14 | tryptophan catabolic process (GO:0006569) | 4.88396099 |
| 15 | indole-containing compound catabolic process (GO:0042436) | 4.88396099 |
| 16 | indolalkylamine catabolic process (GO:0046218) | 4.88396099 |
| 17 | tryptophan metabolic process (GO:0006568) | 4.55916239 |
| 18 | high-density lipoprotein particle remodeling (GO:0034375) | 4.53675209 |
| 19 | kynurenine metabolic process (GO:0070189) | 4.52267225 |
| 20 | mature B cell differentiation involved in immune response (GO:0002313) | 4.50005807 |
| 21 | urea metabolic process (GO:0019627) | 4.42446237 |
| 22 | urea cycle (GO:0000050) | 4.42446237 |
| 23 | regulation of cholesterol esterification (GO:0010872) | 4.39353580 |
| 24 | bile acid biosynthetic process (GO:0006699) | 4.34346079 |
| 25 | phospholipid efflux (GO:0033700) | 4.31650981 |
| 26 | neutrophil activation involved in immune response (GO:0002283) | 4.21360812 |
| 27 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.17409308 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 4.12825751 |
| 29 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.11410121 |
| 30 | imidazole-containing compound metabolic process (GO:0052803) | 4.07599210 |
| 31 | negative regulation of neurotransmitter transport (GO:0051589) | 4.07223166 |
| 32 | alpha-linolenic acid metabolic process (GO:0036109) | 4.03007699 |
| 33 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.00643128 |
| 34 | complement activation, alternative pathway (GO:0006957) | 3.98712642 |
| 35 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.97817176 |
| 36 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.95278308 |
| 37 | protein carboxylation (GO:0018214) | 3.95278308 |
| 38 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.94190314 |
| 39 | Peyers patch development (GO:0048541) | 3.94190314 |
| 40 | immunoglobulin mediated immune response (GO:0016064) | 3.93800681 |
| 41 | reverse cholesterol transport (GO:0043691) | 3.92459495 |
| 42 | protein-lipid complex remodeling (GO:0034368) | 3.88568016 |
| 43 | macromolecular complex remodeling (GO:0034367) | 3.88568016 |
| 44 | plasma lipoprotein particle remodeling (GO:0034369) | 3.88568016 |
| 45 | regulation of triglyceride catabolic process (GO:0010896) | 3.87262385 |
| 46 | regulation of fibrinolysis (GO:0051917) | 3.77993295 |
| 47 | negative regulation of fibrinolysis (GO:0051918) | 3.77502227 |
| 48 | low-density lipoprotein particle remodeling (GO:0034374) | 3.76268873 |
| 49 | aromatic amino acid family metabolic process (GO:0009072) | 3.74764060 |
| 50 | bile acid metabolic process (GO:0008206) | 3.74142664 |
| 51 | cholesterol efflux (GO:0033344) | 3.71768019 |
| 52 | cysteine metabolic process (GO:0006534) | 3.70219934 |
| 53 | glyoxylate metabolic process (GO:0046487) | 3.69457175 |
| 54 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.68222040 |
| 55 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.68222040 |
| 56 | mature B cell differentiation (GO:0002335) | 3.67966653 |
| 57 | regulation of protein activation cascade (GO:2000257) | 3.63000506 |
| 58 | response to peptidoglycan (GO:0032494) | 3.59886081 |
| 59 | negative regulation of cholesterol transport (GO:0032375) | 3.56830228 |
| 60 | negative regulation of sterol transport (GO:0032372) | 3.56830228 |
| 61 | negative regulation of interleukin-12 production (GO:0032695) | 3.55134488 |
| 62 | regulation of amino acid transport (GO:0051955) | 3.51311756 |
| 63 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.50184424 |
| 64 | sulfur amino acid catabolic process (GO:0000098) | 3.49221064 |
| 65 | tyrosine metabolic process (GO:0006570) | 3.48249458 |
| 66 | amine catabolic process (GO:0009310) | 3.47369391 |
| 67 | cellular biogenic amine catabolic process (GO:0042402) | 3.47369391 |
| 68 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.45141942 |
| 69 | indolalkylamine metabolic process (GO:0006586) | 3.43172473 |
| 70 | serine family amino acid catabolic process (GO:0009071) | 3.42267214 |
| 71 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.42018214 |
| 72 | triglyceride homeostasis (GO:0070328) | 3.41691180 |
| 73 | acylglycerol homeostasis (GO:0055090) | 3.41691180 |
| 74 | NAD biosynthetic process (GO:0009435) | 3.38850179 |
| 75 | alpha-amino acid catabolic process (GO:1901606) | 3.37209680 |
| 76 | regulation of complement activation (GO:0030449) | 3.36913079 |
| 77 | negative regulation of cell killing (GO:0031342) | 3.36168194 |
| 78 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.36168194 |
| 79 | plasma lipoprotein particle clearance (GO:0034381) | 3.35917690 |
| 80 | serotonin receptor signaling pathway (GO:0007210) | 3.35204619 |
| 81 | NIK/NF-kappaB signaling (GO:0038061) | 3.34367281 |
| 82 | plasma lipoprotein particle assembly (GO:0034377) | 3.28812035 |
| 83 | response to type I interferon (GO:0034340) | 3.28415015 |
| 84 | type I interferon signaling pathway (GO:0060337) | 3.27191774 |
| 85 | cellular response to type I interferon (GO:0071357) | 3.27191774 |
| 86 | positive regulation of granulocyte differentiation (GO:0030854) | 3.26753834 |
| 87 | regulation of interferon-alpha production (GO:0032647) | 3.22898477 |
| 88 | amino-acid betaine metabolic process (GO:0006577) | 3.21325070 |
| 89 | negative regulation of organic acid transport (GO:0032891) | 3.19633273 |
| 90 | phospholipid homeostasis (GO:0055091) | 3.19235594 |
| 91 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.18098490 |
| 92 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.18098490 |
| 93 | bile acid and bile salt transport (GO:0015721) | 3.17831361 |
| 94 | valine metabolic process (GO:0006573) | 3.17526303 |
| 95 | drug catabolic process (GO:0042737) | 3.17034411 |
| 96 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.16564357 |
| 97 | defense response to protozoan (GO:0042832) | 3.15766213 |
| 98 | positive regulation of organic acid transport (GO:0032892) | 3.15606217 |
| 99 | regulation of chronic inflammatory response (GO:0002676) | 3.15039665 |
| 100 | coenzyme catabolic process (GO:0009109) | 3.13288112 |
| 101 | glutamate metabolic process (GO:0006536) | 3.11373549 |
| 102 | benzene-containing compound metabolic process (GO:0042537) | 3.11206181 |
| 103 | plasma lipoprotein particle organization (GO:0071827) | 3.10206716 |
| 104 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.09973997 |
| 105 | cofactor catabolic process (GO:0051187) | 3.07077424 |
| 106 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.07001113 |
| 107 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.07001113 |
| 108 | positive regulation of lipid catabolic process (GO:0050996) | 3.05669863 |
| 109 | regulation of gamma-delta T cell activation (GO:0046643) | 3.03790267 |
| 110 | negative regulation of lipase activity (GO:0060192) | 3.03321433 |
| 111 | response to protozoan (GO:0001562) | 3.03195366 |
| 112 | cellular amino acid catabolic process (GO:0009063) | 3.03110149 |
| 113 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.03087464 |
| 114 | complement activation, classical pathway (GO:0006958) | 3.02677000 |
| 115 | homocysteine metabolic process (GO:0050667) | 3.01008218 |
| 116 | blood coagulation, intrinsic pathway (GO:0007597) | 2.99286729 |
| 117 | opsonization (GO:0008228) | 2.99016175 |
| 118 | B cell mediated immunity (GO:0019724) | 2.97531000 |
| 119 | protein activation cascade (GO:0072376) | 2.97205599 |
| 120 | regulation of antigen processing and presentation (GO:0002577) | 2.97071665 |
| 121 | complement activation (GO:0006956) | 2.96953998 |
| 122 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.93129700 |
| 123 | granulocyte activation (GO:0036230) | 2.93006223 |
| 124 | protein-lipid complex assembly (GO:0065005) | 2.92702296 |
| 125 | neutrophil activation (GO:0042119) | 2.92566231 |
| 126 | T cell migration (GO:0072678) | 2.91717479 |
| 127 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.91465935 |
| 128 | regulation of germinal center formation (GO:0002634) | 2.90952537 |
| 129 | arginine metabolic process (GO:0006525) | 2.90947152 |
| 130 | protein-lipid complex subunit organization (GO:0071825) | 2.90440114 |
| 131 | N-glycan processing (GO:0006491) | 2.90353191 |
| 132 | positive thymic T cell selection (GO:0045059) | 2.89176335 |
| 133 | cellular ketone body metabolic process (GO:0046950) | 2.88723612 |
| 134 | lysine metabolic process (GO:0006553) | 2.88684563 |
| 135 | lysine catabolic process (GO:0006554) | 2.88684563 |
| 136 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.86878351 |
| 137 | positive regulation of antigen processing and presentation (GO:0002579) | 2.86634526 |
| 138 | regulation of T-helper cell differentiation (GO:0045622) | 2.86068931 |
| 139 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.85581307 |
| 140 | cellular modified amino acid catabolic process (GO:0042219) | 2.85429134 |
| 141 | positive regulation of interferon-alpha production (GO:0032727) | 2.85211480 |
| 142 | acute-phase response (GO:0006953) | 2.84654250 |
| 143 | negative regulation of amine transport (GO:0051953) | 2.84337717 |
| 144 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.84167766 |
| 145 | ethanol oxidation (GO:0006069) | 2.84167112 |
| 146 | positive regulation of humoral immune response (GO:0002922) | 2.82572467 |
| 147 | cholesterol homeostasis (GO:0042632) | 2.81606979 |
| 148 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.81552983 |
| 149 | regulation of membrane lipid distribution (GO:0097035) | 2.81205043 |
| 150 | macrophage activation involved in immune response (GO:0002281) | 2.80830746 |
| 151 | myeloid cell activation involved in immune response (GO:0002275) | 2.80747556 |
| 152 | aldehyde catabolic process (GO:0046185) | 2.79666603 |
| 153 | positive regulation of type 2 immune response (GO:0002830) | 2.79419494 |
| 154 | short-chain fatty acid metabolic process (GO:0046459) | 2.79037950 |
| 155 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.78994914 |
| 156 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.78304121 |
| 157 | regulation of humoral immune response (GO:0002920) | 2.77637876 |
| 158 | cellular glucuronidation (GO:0052695) | 2.76776303 |
| 159 | detection of other organism (GO:0098543) | 2.76542977 |
| 160 | positive regulation of B cell differentiation (GO:0045579) | 2.76038790 |
| 161 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.73851930 |
| 162 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.73226555 |
| 163 | detection of bacterium (GO:0016045) | 2.72037214 |
| 164 | regulation of chemokine biosynthetic process (GO:0045073) | 2.71797796 |
| 165 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.70923067 |
| 166 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.68965540 |
| 167 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.67873032 |
| 168 | positive regulation of interleukin-17 production (GO:0032740) | 2.67465892 |
| 169 | positive regulation of defense response to virus by host (GO:0002230) | 2.65257891 |
| 170 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.63509628 |
| 171 | regulation of T cell tolerance induction (GO:0002664) | 2.63260925 |
| 172 | response to muramyl dipeptide (GO:0032495) | 2.62619662 |
| 173 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.61841586 |
| 174 | regulation of growth of symbiont in host (GO:0044126) | 2.61841586 |
| 175 | negative regulation of growth of symbiont in host (GO:0044130) | 2.61841586 |
| 176 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.61841586 |
| 177 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.61373624 |
| 178 | regulation of mast cell degranulation (GO:0043304) | 2.61135077 |
| 179 | cellular response to interferon-gamma (GO:0071346) | 2.60931133 |
| 180 | negative regulation of T cell mediated immunity (GO:0002710) | 2.58444107 |
| 181 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.58121821 |
| 182 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.57730401 |
| 183 | germinal center formation (GO:0002467) | 2.56796730 |
| 184 | negative thymic T cell selection (GO:0045060) | 2.55189660 |
| 185 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.54961259 |
| 186 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.54947718 |
| 187 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.54251432 |
| 188 | regulation of tolerance induction (GO:0002643) | 2.53159498 |
| 189 | T-helper 1 type immune response (GO:0042088) | 2.52583482 |
| 190 | regulation of interleukin-12 production (GO:0032655) | 2.51547001 |
| 191 | regulation of mast cell activation (GO:0033003) | 2.50534253 |
| 192 | positive regulation of interferon-beta production (GO:0032728) | 2.49388071 |
| 193 | cellular response to exogenous dsRNA (GO:0071360) | 2.49035210 |
| 194 | negative T cell selection (GO:0043383) | 2.46195763 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.88090204 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.71585631 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.95123998 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.93261304 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.85666646 |
| 6 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.46573424 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.72926643 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.59160519 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.51996646 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.17753918 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.13132099 |
| 12 | GATA1_22025678_ChIP-Seq_K562_Human | 3.12539057 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.91258902 |
| 14 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.90180004 |
| 15 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.42207890 |
| 16 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.31937371 |
| 17 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.28978018 |
| 18 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.19035353 |
| 19 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.17144308 |
| 20 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.12214576 |
| 21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.03201811 |
| 22 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.94289274 |
| 23 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.87944095 |
| 24 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.83392487 |
| 25 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.75773973 |
| 26 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.73716485 |
| 27 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.67524274 |
| 28 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.66491965 |
| 29 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.63474800 |
| 30 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.63172491 |
| 31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62920862 |
| 32 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.57700221 |
| 33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.49756751 |
| 34 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.49227958 |
| 35 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.49014349 |
| 36 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.46839834 |
| 37 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42713417 |
| 38 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.41785436 |
| 39 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.37136991 |
| 40 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.32135698 |
| 41 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28679492 |
| 42 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27403366 |
| 43 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.22305310 |
| 44 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.21166424 |
| 45 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18923509 |
| 46 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.18231098 |
| 47 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17760450 |
| 48 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12055327 |
| 49 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.11325116 |
| 50 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.08888377 |
| 51 | MYB_26560356_Chip-Seq_TH2_Human | 1.08564383 |
| 52 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07636466 |
| 53 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.06362703 |
| 54 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.03030499 |
| 55 | MAF_26560356_Chip-Seq_TH1_Human | 1.03000440 |
| 56 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.00458477 |
| 57 | MYB_26560356_Chip-Seq_TH1_Human | 1.00218058 |
| 58 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.99148212 |
| 59 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.97409865 |
| 60 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.97141367 |
| 61 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.95065253 |
| 62 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94405885 |
| 63 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92952739 |
| 64 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.92234226 |
| 65 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91429516 |
| 66 | UTX_26944678_Chip-Seq_JUKART_Human | 0.90434214 |
| 67 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.89373841 |
| 68 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88987389 |
| 69 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87736723 |
| 70 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.87664017 |
| 71 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.87642924 |
| 72 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.87003913 |
| 73 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86993155 |
| 74 | GATA1_19941826_ChIP-Seq_K562_Human | 0.86044104 |
| 75 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.85495532 |
| 76 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85442036 |
| 77 | GATA2_19941826_ChIP-Seq_K562_Human | 0.85221884 |
| 78 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.84311625 |
| 79 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82449017 |
| 80 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.81754778 |
| 81 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.81615005 |
| 82 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.80924204 |
| 83 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.79958380 |
| 84 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.79813271 |
| 85 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79570681 |
| 86 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.78913054 |
| 87 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.78531658 |
| 88 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.78292763 |
| 89 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.77926322 |
| 90 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.77798206 |
| 91 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.77719422 |
| 92 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.76360303 |
| 93 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.75236797 |
| 94 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73270984 |
| 95 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.73107680 |
| 96 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.73068388 |
| 97 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.72131682 |
| 98 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.71994537 |
| 99 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.71713083 |
| 100 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.71713083 |
| 101 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.71316834 |
| 102 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.71239849 |
| 103 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.71227305 |
| 104 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.71018234 |
| 105 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.70509864 |
| 106 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.69982304 |
| 107 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.69505513 |
| 108 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.69377544 |
| 109 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.69328081 |
| 110 | VDR_22108803_ChIP-Seq_LS180_Human | 0.69285252 |
| 111 | SPI1_23127762_ChIP-Seq_K562_Human | 0.67928124 |
| 112 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.67489375 |
| 113 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.67316654 |
| 114 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.65595770 |
| 115 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.63529999 |
| 116 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.62219312 |
| 117 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.62189951 |
| 118 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.62001232 |
| 119 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.60853381 |
| 120 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60760048 |
| 121 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.60733405 |
| 122 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.60594973 |
| 123 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.59657129 |
| 124 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.59578372 |
| 125 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.59511093 |
| 126 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.58175214 |
| 127 | * GATA3_26560356_Chip-Seq_TH1_Human | 0.58112657 |
| 128 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.57979632 |
| 129 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.57851844 |
| 130 | MAF_26560356_Chip-Seq_TH2_Human | 0.57315471 |
| 131 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.56818178 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.37336815 |
| 2 | MP0005360_urolithiasis | 4.70749834 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.30776002 |
| 4 | MP0005365_abnormal_bile_salt | 4.20808681 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.52298200 |
| 6 | MP0002254_reproductive_system_inflammat | 3.45446959 |
| 7 | MP0001835_abnormal_antigen_presentation | 3.11654024 |
| 8 | MP0002138_abnormal_hepatobiliary_system | 2.85402224 |
| 9 | MP0009840_abnormal_foam_cell | 2.82611685 |
| 10 | MP0008961_abnormal_basal_metabolism | 2.78752982 |
| 11 | MP0000685_abnormal_immune_system | 2.73138227 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.56128071 |
| 13 | MP0003252_abnormal_bile_duct | 2.53326175 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.37189425 |
| 15 | MP0002876_abnormal_thyroid_physiology | 2.21814927 |
| 16 | MP0009278_abnormal_bone_marrow | 2.21204705 |
| 17 | MP0003195_calcinosis | 2.18862899 |
| 18 | MP0002396_abnormal_hematopoietic_system | 2.04410982 |
| 19 | MP0005397_hematopoietic_system_phenotyp | 2.01904295 |
| 20 | MP0001545_abnormal_hematopoietic_system | 2.01904295 |
| 21 | MP0009785_altered_susceptibility_to | 1.99907659 |
| 22 | MP0005671_abnormal_response_to | 1.99697619 |
| 23 | MP0005387_immune_system_phenotype | 1.96094201 |
| 24 | MP0001790_abnormal_immune_system | 1.96094201 |
| 25 | MP0003806_abnormal_nucleotide_metabolis | 1.92995327 |
| 26 | MP0005332_abnormal_amino_acid | 1.89696203 |
| 27 | MP0002822_catalepsy | 1.88341924 |
| 28 | MP0005083_abnormal_biliary_tract | 1.87734999 |
| 29 | MP0005167_abnormal_blood-brain_barrier | 1.85253173 |
| 30 | MP0006082_CNS_inflammation | 1.84819006 |
| 31 | MP0003436_decreased_susceptibility_to | 1.83516704 |
| 32 | MP0000609_abnormal_liver_physiology | 1.82926493 |
| 33 | MP0001666_abnormal_nutrient_absorption | 1.76479185 |
| 34 | MP0004510_myositis | 1.70316122 |
| 35 | MP0001800_abnormal_humoral_immune | 1.65566114 |
| 36 | MP0002118_abnormal_lipid_homeostasis | 1.62951992 |
| 37 | MP0005025_abnormal_response_to | 1.62521777 |
| 38 | MP0001764_abnormal_homeostasis | 1.58978931 |
| 39 | MP0002148_abnormal_hypersensitivity_rea | 1.58664704 |
| 40 | MP0001873_stomach_inflammation | 1.57363982 |
| 41 | MP0005000_abnormal_immune_tolerance | 1.56657890 |
| 42 | MP0004808_abnormal_hematopoietic_stem | 1.55910041 |
| 43 | MP0002419_abnormal_innate_immunity | 1.55291074 |
| 44 | MP0005464_abnormal_platelet_physiology | 1.48777162 |
| 45 | MP0008004_abnormal_stomach_pH | 1.47255217 |
| 46 | MP0009333_abnormal_splenocyte_physiolog | 1.46816066 |
| 47 | MP0009764_decreased_sensitivity_to | 1.46442257 |
| 48 | MP0005310_abnormal_salivary_gland | 1.45889686 |
| 49 | MP0008469_abnormal_protein_level | 1.45292579 |
| 50 | MP0003828_pulmonary_edema | 1.43252978 |
| 51 | MP0002723_abnormal_immune_serum | 1.42761075 |
| 52 | MP0001853_heart_inflammation | 1.41133828 |
| 53 | MP0003656_abnormal_erythrocyte_physiolo | 1.40933341 |
| 54 | MP0003724_increased_susceptibility_to | 1.40682390 |
| 55 | MP0003868_abnormal_feces_composition | 1.39541008 |
| 56 | MP0005319_abnormal_enzyme/_coenzyme | 1.39516299 |
| 57 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.38301303 |
| 58 | MP0004019_abnormal_vitamin_homeostasis | 1.34845766 |
| 59 | MP0002452_abnormal_antigen_presenting | 1.34593518 |
| 60 | MP0001348_abnormal_lacrimal_gland | 1.28134948 |
| 61 | MP0002166_altered_tumor_susceptibility | 1.27741405 |
| 62 | MP0000465_gastrointestinal_hemorrhage | 1.26474248 |
| 63 | MP0001501_abnormal_sleep_pattern | 1.23373545 |
| 64 | MP0001845_abnormal_inflammatory_respons | 1.22894062 |
| 65 | MP0001819_abnormal_immune_cell | 1.21756134 |
| 66 | MP0002420_abnormal_adaptive_immunity | 1.21099386 |
| 67 | MP0000604_amyloidosis | 1.20394092 |
| 68 | MP0003763_abnormal_thymus_physiology | 1.13992145 |
| 69 | MP0002735_abnormal_chemical_nociception | 1.13375697 |
| 70 | MP0009763_increased_sensitivity_to | 1.11367222 |
| 71 | MP0003866_abnormal_defecation | 1.09164766 |
| 72 | MP0006054_spinal_hemorrhage | 1.09011533 |
| 73 | MP0009643_abnormal_urine_homeostasis | 1.08208695 |
| 74 | MP0005535_abnormal_body_temperature | 1.07595288 |
| 75 | MP0004883_abnormal_blood_vessel | 1.06452973 |
| 76 | MP0003075_altered_response_to | 1.02825572 |
| 77 | MP0009765_abnormal_xenobiotic_induced | 1.01696588 |
| 78 | MP0002332_abnormal_exercise_endurance | 1.00538692 |
| 79 | MP0003172_abnormal_lysosome_physiology | 0.99488163 |
| 80 | MP0005647_abnormal_sex_gland | 0.99359558 |
| 81 | MP0000716_abnormal_immune_system | 0.99204396 |
| 82 | MP0002405_respiratory_system_inflammati | 0.97507372 |
| 83 | MP0005058_abnormal_lysosome_morphology | 0.96659696 |
| 84 | MP0005645_abnormal_hypothalamus_physiol | 0.96492586 |
| 85 | MP0010155_abnormal_intestine_physiology | 0.94926411 |
| 86 | MP0002971_abnormal_brown_adipose | 0.94413042 |
| 87 | MP0000920_abnormal_myelination | 0.94070153 |
| 88 | MP0002998_abnormal_bone_remodeling | 0.93891484 |
| 89 | MP0003453_abnormal_keratinocyte_physiol | 0.92707515 |
| 90 | MP0003690_abnormal_glial_cell | 0.92121338 |
| 91 | MP0004947_skin_inflammation | 0.89745229 |
| 92 | MP0000598_abnormal_liver_morphology | 0.89301076 |
| 93 | MP0008874_decreased_physiological_sensi | 0.88973247 |
| 94 | MP0003186_abnormal_redox_activity | 0.88470383 |
| 95 | MP0003646_muscle_fatigue | 0.88436968 |
| 96 | MP0002398_abnormal_bone_marrow | 0.88037113 |
| 97 | MP0005334_abnormal_fat_pad | 0.87856714 |
| 98 | MP0000703_abnormal_thymus_morphology | 0.86580942 |
| 99 | MP0008872_abnormal_physiological_respon | 0.85637570 |
| 100 | MP0005164_abnormal_response_to | 0.85439610 |
| 101 | MP0009642_abnormal_blood_homeostasis | 0.85356563 |
| 102 | MP0003303_peritoneal_inflammation | 0.85065230 |
| 103 | MP0002078_abnormal_glucose_homeostasis | 0.84064520 |
| 104 | MP0000343_altered_response_to | 0.83245284 |
| 105 | MP0002933_joint_inflammation | 0.80886810 |
| 106 | MP0001346_abnormal_lacrimal_gland | 0.80295862 |
| 107 | MP0001663_abnormal_digestive_system | 0.80247316 |
| 108 | MP0003183_abnormal_peptide_metabolism | 0.79880402 |
| 109 | MP0000689_abnormal_spleen_morphology | 0.79781212 |
| 110 | MP0005636_abnormal_mineral_homeostasis | 0.79643216 |
| 111 | MP0005451_abnormal_body_composition | 0.79469407 |
| 112 | MP0005379_endocrine/exocrine_gland_phen | 0.79391995 |
| 113 | MP0001851_eye_inflammation | 0.78889081 |
| 114 | MP0002006_tumorigenesis | 0.78842526 |
| 115 | MP0002693_abnormal_pancreas_physiology | 0.76023588 |
| 116 | MP0002429_abnormal_blood_cell | 0.75671234 |
| 117 | MP0005448_abnormal_energy_balance | 0.74416676 |
| 118 | MP0004484_altered_response_of | 0.74357496 |
| 119 | MP0009697_abnormal_copulation | 0.73886210 |
| 120 | MP0001533_abnormal_skeleton_physiology | 0.71834487 |
| 121 | MP0004130_abnormal_muscle_cell | 0.71277874 |
| 122 | MP0002722_abnormal_immune_system | 0.70854020 |
| 123 | MP0000249_abnormal_blood_vessel | 0.69284956 |
| 124 | MP0003300_gastrointestinal_ulcer | 0.68910407 |
| 125 | MP0005670_abnormal_white_adipose | 0.67585275 |
| 126 | MP0003638_abnormal_response/metabolism_ | 0.67479865 |
| 127 | MP0000858_altered_metastatic_potential | 0.67290369 |
| 128 | MP0004782_abnormal_surfactant_physiolog | 0.66554317 |
| 129 | MP0003879_abnormal_hair_cell | 0.65216488 |
| 130 | MP0000678_abnormal_parathyroid_gland | 0.62270046 |
| 131 | MP0002136_abnormal_kidney_physiology | 0.61610168 |
| 132 | MP0005166_decreased_susceptibility_to | 0.60984108 |
| 133 | MP0003448_altered_tumor_morphology | 0.58987126 |
| 134 | MP0001986_abnormal_taste_sensitivity | 0.58861347 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.92907964 |
| 2 | Prolonged partial thromboplastin time (HP:0003645) | 5.13969602 |
| 3 | Deep venous thrombosis (HP:0002625) | 4.94078135 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 4.60756720 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.53485194 |
| 6 | Stomatitis (HP:0010280) | 4.51531040 |
| 7 | Optic neuritis (HP:0100653) | 4.50362002 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 4.50362002 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 4.48566074 |
| 10 | Xanthomatosis (HP:0000991) | 4.46155209 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 4.23184365 |
| 12 | Complement deficiency (HP:0004431) | 4.18344184 |
| 13 | Abnormality of glycolipid metabolism (HP:0010969) | 4.04444037 |
| 14 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.04444037 |
| 15 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.04444037 |
| 16 | Joint hemorrhage (HP:0005261) | 3.95519311 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 3.61295261 |
| 18 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.51372263 |
| 19 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.37630998 |
| 20 | Keratoconjunctivitis sicca (HP:0001097) | 3.34118973 |
| 21 | Systemic lupus erythematosus (HP:0002725) | 3.25449800 |
| 22 | Hyperammonemia (HP:0001987) | 3.23772973 |
| 23 | Hypolipoproteinemia (HP:0010981) | 3.20858167 |
| 24 | Ketosis (HP:0001946) | 3.19535018 |
| 25 | Abnormality of complement system (HP:0005339) | 3.15740932 |
| 26 | Epidermoid cyst (HP:0200040) | 3.14798543 |
| 27 | Pulmonary infiltrates (HP:0002113) | 3.13739342 |
| 28 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.05338970 |
| 29 | Eczematoid dermatitis (HP:0000976) | 3.03380977 |
| 30 | Myocardial infarction (HP:0001658) | 3.02917820 |
| 31 | Encephalitis (HP:0002383) | 3.01626938 |
| 32 | Gingival bleeding (HP:0000225) | 2.97253669 |
| 33 | Hypoglycemic coma (HP:0001325) | 2.94846226 |
| 34 | Conjugated hyperbilirubinemia (HP:0002908) | 2.93993533 |
| 35 | Recurrent bacterial skin infections (HP:0005406) | 2.93645211 |
| 36 | Fat malabsorption (HP:0002630) | 2.93530409 |
| 37 | Prolonged bleeding time (HP:0003010) | 2.91791417 |
| 38 | Abnormality of the intrinsic pathway (HP:0010989) | 2.91639098 |
| 39 | Autoimmune hemolytic anemia (HP:0001890) | 2.90660974 |
| 40 | Gangrene (HP:0100758) | 2.89960908 |
| 41 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.87114514 |
| 42 | Dysostosis multiplex (HP:0000943) | 2.85628453 |
| 43 | Short 1st metacarpal (HP:0010034) | 2.83936354 |
| 44 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.83936354 |
| 45 | Hemoptysis (HP:0002105) | 2.83454331 |
| 46 | Hyperglycinemia (HP:0002154) | 2.81335369 |
| 47 | Abnormality of B cell number (HP:0010975) | 2.79939764 |
| 48 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.79435100 |
| 49 | Recurrent skin infections (HP:0001581) | 2.77876141 |
| 50 | Hypercholesterolemia (HP:0003124) | 2.76676418 |
| 51 | Hyperglycinuria (HP:0003108) | 2.72806969 |
| 52 | Hypoalphalipoproteinemia (HP:0003233) | 2.72208887 |
| 53 | Abnormality of the renal collecting system (HP:0004742) | 2.71391327 |
| 54 | Glomerulonephritis (HP:0000099) | 2.70716028 |
| 55 | Hyperbilirubinemia (HP:0002904) | 2.69503585 |
| 56 | Abnormality of methionine metabolism (HP:0010901) | 2.66773388 |
| 57 | Obstructive lung disease (HP:0006536) | 2.66120067 |
| 58 | Chronic obstructive pulmonary disease (HP:0006510) | 2.66120067 |
| 59 | Abnormality of the prostate (HP:0008775) | 2.65506749 |
| 60 | Amyloidosis (HP:0011034) | 2.61939790 |
| 61 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.60735962 |
| 62 | Anorexia (HP:0002039) | 2.60314024 |
| 63 | T lymphocytopenia (HP:0005403) | 2.60218721 |
| 64 | Abnormality of T cell number (HP:0011839) | 2.58125437 |
| 65 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.58118437 |
| 66 | Abnormality of glycine metabolism (HP:0010895) | 2.58118437 |
| 67 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.56784597 |
| 68 | Panhypogammaglobulinemia (HP:0003139) | 2.54883045 |
| 69 | Recurrent cutaneous fungal infections (HP:0011370) | 2.52288772 |
| 70 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.52288772 |
| 71 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.52130831 |
| 72 | Abnormality of the 1st metacarpal (HP:0010009) | 2.51797960 |
| 73 | Spontaneous abortion (HP:0005268) | 2.51191033 |
| 74 | Petechiae (HP:0000967) | 2.51081193 |
| 75 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.50254409 |
| 76 | Recurrent fungal infections (HP:0002841) | 2.48621268 |
| 77 | B lymphocytopenia (HP:0010976) | 2.47272100 |
| 78 | Recurrent abscess formation (HP:0002722) | 2.45739678 |
| 79 | Spontaneous hematomas (HP:0007420) | 2.43511426 |
| 80 | Loss of speech (HP:0002371) | 2.43247593 |
| 81 | Leukocytosis (HP:0001974) | 2.39922750 |
| 82 | Abnormality of the pleura (HP:0002103) | 2.38908386 |
| 83 | Epistaxis (HP:0000421) | 2.36159668 |
| 84 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.35865179 |
| 85 | Hydroxyprolinuria (HP:0003080) | 2.33981662 |
| 86 | Abnormality of proline metabolism (HP:0010907) | 2.33981662 |
| 87 | Ketoacidosis (HP:0001993) | 2.33368275 |
| 88 | Severe combined immunodeficiency (HP:0004430) | 2.32071699 |
| 89 | Abnormality of nucleobase metabolism (HP:0010932) | 2.31967440 |
| 90 | Thrombophlebitis (HP:0004418) | 2.31966898 |
| 91 | Myositis (HP:0100614) | 2.30172986 |
| 92 | Vacuolated lymphocytes (HP:0001922) | 2.29950915 |
| 93 | Increased IgE level (HP:0003212) | 2.27944889 |
| 94 | Steatorrhea (HP:0002570) | 2.27837008 |
| 95 | Eosinophilia (HP:0001880) | 2.27446764 |
| 96 | Vertigo (HP:0002321) | 2.26942461 |
| 97 | Increased cerebral lipofuscin (HP:0011813) | 2.26867631 |
| 98 | Granulocytopenia (HP:0001913) | 2.26712900 |
| 99 | Acanthocytosis (HP:0001927) | 2.26587845 |
| 100 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.25543448 |
| 101 | Pulmonary embolism (HP:0002204) | 2.25348205 |
| 102 | Agammaglobulinemia (HP:0004432) | 2.22635756 |
| 103 | Gastrointestinal infarctions (HP:0005244) | 2.21889581 |
| 104 | Chronic otitis media (HP:0000389) | 2.21107883 |
| 105 | Increased serum ferritin (HP:0003281) | 2.20980665 |
| 106 | Joint swelling (HP:0001386) | 2.20589728 |
| 107 | Hypergammaglobulinemia (HP:0010702) | 2.20205693 |
| 108 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.19762348 |
| 109 | Fused cervical vertebrae (HP:0002949) | 2.19654232 |
| 110 | Abnormality of purine metabolism (HP:0004352) | 2.19558862 |
| 111 | Pancreatitis (HP:0001733) | 2.18858230 |
| 112 | Hypoglycemic seizures (HP:0002173) | 2.18491095 |
| 113 | Keratoconjunctivitis (HP:0001096) | 2.17857078 |
| 114 | Chest pain (HP:0100749) | 2.17665301 |
| 115 | Disinhibition (HP:0000734) | 2.17485172 |
| 116 | Menorrhagia (HP:0000132) | 2.15658057 |
| 117 | Episodic fever (HP:0001954) | 2.14185336 |
| 118 | Vasculitis (HP:0002633) | 2.14163321 |
| 119 | Recurrent bronchitis (HP:0002837) | 2.13832903 |
| 120 | Mitral stenosis (HP:0001718) | 2.13642833 |
| 121 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.13345533 |
| 122 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.13345533 |
| 123 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.13345533 |
| 124 | Abnormal gallbladder morphology (HP:0012437) | 2.13096643 |
| 125 | Acute lymphatic leukemia (HP:0006721) | 2.10620326 |
| 126 | Cholelithiasis (HP:0001081) | 2.09935270 |
| 127 | Abnormality of macrophages (HP:0004311) | 2.07494012 |
| 128 | Abnormality of T cells (HP:0002843) | 2.07393034 |
| 129 | Autoimmune thrombocytopenia (HP:0001973) | 2.05632066 |
| 130 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.05532457 |
| 131 | Mucopolysacchariduria (HP:0008155) | 2.05532457 |
| 132 | Polyneuropathy (HP:0001271) | 2.04904128 |
| 133 | Brushfield spots (HP:0001088) | 2.02172459 |
| 134 | Delayed CNS myelination (HP:0002188) | 2.01489235 |
| 135 | Metabolic acidosis (HP:0001942) | 2.01483844 |
| 136 | Pustule (HP:0200039) | 1.99184198 |
| 137 | Abnormality of eosinophils (HP:0001879) | 1.98628179 |
| 138 | IgG deficiency (HP:0004315) | 1.98048114 |
| 139 | Hepatocellular carcinoma (HP:0001402) | 1.97951323 |
| 140 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.97909323 |
| 141 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.96473796 |
| 142 | Acute hepatic failure (HP:0006554) | 1.96410441 |
| 143 | Abnormality of serum amino acid levels (HP:0003112) | 1.95620759 |
| 144 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.95539732 |
| 145 | Abnormality of iron homeostasis (HP:0011031) | 1.92525870 |
| 146 | Colitis (HP:0002583) | 1.92244119 |
| 147 | Hypoplasia of the thymus (HP:0000778) | 1.91052777 |
| 148 | Poikilocytosis (HP:0004447) | 1.90559883 |
| 149 | Skin nodule (HP:0200036) | 1.90155984 |
| 150 | Urticaria (HP:0001025) | 1.89694104 |
| 151 | Elevated hepatic transaminases (HP:0002910) | 1.88096476 |
| 152 | Nasal polyposis (HP:0100582) | 1.88062976 |
| 153 | Increased IgM level (HP:0003496) | 1.87824362 |
| 154 | Orchitis (HP:0100796) | 1.87558150 |
| 155 | Recurrent viral infections (HP:0004429) | 1.87476678 |
| 156 | Purpura (HP:0000979) | 1.86490444 |
| 157 | Mediastinal lymphadenopathy (HP:0100721) | 1.86025353 |
| 158 | Arterial thrombosis (HP:0004420) | 1.83129220 |
| 159 | Nephritis (HP:0000123) | 1.83086330 |
| 160 | Meningitis (HP:0001287) | 1.82782571 |
| 161 | Sensorimotor neuropathy (HP:0007141) | 1.81763884 |
| 162 | Dicarboxylic aciduria (HP:0003215) | 1.80569219 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.26942120 |
| 2 | EIF2AK3 | 3.53532305 |
| 3 | TYK2 | 3.33226621 |
| 4 | FGFR4 | 3.06598103 |
| 5 | MAP3K13 | 2.98836161 |
| 6 | MAP4K1 | 2.71661976 |
| 7 | BCKDK | 2.65804709 |
| 8 | TBK1 | 2.61722940 |
| 9 | IKBKE | 2.46466447 |
| 10 | ERN1 | 2.38145809 |
| 11 | JAK1 | 2.38055911 |
| 12 | IRAK4 | 2.27914492 |
| 13 | RIPK4 | 2.25210354 |
| 14 | TAOK3 | 2.19017104 |
| 15 | IKBKB | 2.14777377 |
| 16 | JAK3 | 2.07838068 |
| 17 | IRAK3 | 2.00690775 |
| 18 | FLT3 | 1.93644164 |
| 19 | KIT | 1.93095657 |
| 20 | TXK | 1.91301382 |
| 21 | SIK1 | 1.73697626 |
| 22 | BLK | 1.69060313 |
| 23 | JAK2 | 1.63195697 |
| 24 | INSRR | 1.61380290 |
| 25 | SYK | 1.56845290 |
| 26 | BTK | 1.46439631 |
| 27 | CSF1R | 1.44703971 |
| 28 | GRK6 | 1.42827139 |
| 29 | ZAP70 | 1.33735677 |
| 30 | EPHB1 | 1.33664977 |
| 31 | TGFBR2 | 1.33114788 |
| 32 | ITK | 1.32426509 |
| 33 | TEC | 1.28892445 |
| 34 | CHUK | 1.27221041 |
| 35 | NLK | 1.27171015 |
| 36 | FGFR3 | 1.24302659 |
| 37 | BMPR2 | 1.21324899 |
| 38 | ARAF | 1.17650483 |
| 39 | EIF2AK2 | 1.13744935 |
| 40 | CSK | 1.13404032 |
| 41 | MAP3K12 | 1.10762683 |
| 42 | DAPK2 | 1.09794115 |
| 43 | IRAK1 | 1.08662913 |
| 44 | PRPF4B | 1.06724888 |
| 45 | MAPK11 | 1.05464056 |
| 46 | EPHA3 | 1.02836741 |
| 47 | FES | 1.02215388 |
| 48 | TAOK2 | 0.99474991 |
| 49 | SIK2 | 0.97828434 |
| 50 | MAPK15 | 0.96911939 |
| 51 | PTK6 | 0.93161556 |
| 52 | PRKAA2 | 0.90540840 |
| 53 | HCK | 0.89107615 |
| 54 | MAP2K4 | 0.87960983 |
| 55 | PIK3CG | 0.87642772 |
| 56 | LCK | 0.87623959 |
| 57 | FRK | 0.82403704 |
| 58 | LYN | 0.81409234 |
| 59 | TNK2 | 0.80334855 |
| 60 | TNIK | 0.79588386 |
| 61 | PRKCQ | 0.77206119 |
| 62 | MAP3K1 | 0.74289327 |
| 63 | CAMKK2 | 0.73975124 |
| 64 | FGR | 0.73222930 |
| 65 | ADRBK2 | 0.69419573 |
| 66 | DYRK1B | 0.68492725 |
| 67 | MAP3K7 | 0.68104457 |
| 68 | PIM2 | 0.67795588 |
| 69 | MAP4K2 | 0.67699561 |
| 70 | GRK7 | 0.66031548 |
| 71 | PRKD2 | 0.59706260 |
| 72 | ACVR1B | 0.59575009 |
| 73 | MAP3K3 | 0.58488885 |
| 74 | SIK3 | 0.56725663 |
| 75 | PDK1 | 0.55569063 |
| 76 | NME2 | 0.55291670 |
| 77 | TAOK1 | 0.54706104 |
| 78 | MAPK12 | 0.54249501 |
| 79 | PRKG2 | 0.53194499 |
| 80 | PINK1 | 0.52249469 |
| 81 | GRK5 | 0.52224685 |
| 82 | MAPK4 | 0.51318006 |
| 83 | PKN1 | 0.50265930 |
| 84 | STK38 | 0.49285188 |
| 85 | NEK9 | 0.48676268 |
| 86 | PIM1 | 0.48499728 |
| 87 | DAPK1 | 0.47740551 |
| 88 | MAP3K11 | 0.46441632 |
| 89 | KSR2 | 0.45531565 |
| 90 | INSR | 0.45272161 |
| 91 | RAF1 | 0.45239400 |
| 92 | MAP3K5 | 0.45128064 |
| 93 | CAMKK1 | 0.41635109 |
| 94 | ERBB3 | 0.41631896 |
| 95 | MAPK7 | 0.41144456 |
| 96 | MOS | 0.40680599 |
| 97 | MAP2K3 | 0.40468294 |
| 98 | MARK3 | 0.38157198 |
| 99 | IRAK2 | 0.38054163 |
| 100 | PRKCD | 0.37805061 |
| 101 | MAPKAPK2 | 0.37536014 |
| 102 | ABL2 | 0.37155182 |
| 103 | HIPK2 | 0.36070973 |
| 104 | MATK | 0.35988949 |
| 105 | PDPK1 | 0.35892950 |
| 106 | PRKACG | 0.35718478 |
| 107 | ABL1 | 0.35594428 |
| 108 | MAPK13 | 0.33470419 |
| 109 | DDR2 | 0.33382640 |
| 110 | MAP2K6 | 0.33341379 |
| 111 | KDR | 0.33116220 |
| 112 | IGF1R | 0.32899746 |
| 113 | RET | 0.32723211 |
| 114 | GRK1 | 0.32457577 |
| 115 | CDK19 | 0.32354427 |
| 116 | MST1R | 0.32056918 |
| 117 | RIPK1 | 0.31820284 |
| 118 | PRKCZ | 0.31707271 |
| 119 | PKN2 | 0.31050816 |
| 120 | MAP2K7 | 0.30755566 |
| 121 | MAP3K10 | 0.30362315 |
| 122 | MAP3K2 | 0.28390425 |
| 123 | SCYL2 | 0.28321038 |
| 124 | FYN | 0.26951160 |
| 125 | CDC42BPA | 0.26297317 |
| 126 | TRPM7 | 0.25793899 |
| 127 | STK11 | 0.24698831 |
| 128 | MAPK3 | 0.23802972 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.32408727 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.25182932 |
| 3 | Asthma_Homo sapiens_hsa05310 | 3.55390206 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.00476471 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.92968593 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.81870568 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.61525522 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.54770171 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.53772227 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.27078568 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.23787768 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.08571294 |
| 13 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.03875812 |
| 14 | Histidine metabolism_Homo sapiens_hsa00340 | 2.01842146 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.97822310 |
| 16 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.97728504 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 1.92136986 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.90445420 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.87526683 |
| 20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.83635743 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.81369333 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.70808561 |
| 23 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.68090617 |
| 24 | Malaria_Homo sapiens_hsa05144 | 1.67573368 |
| 25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.63125994 |
| 26 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.62210184 |
| 27 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.61122595 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.55441679 |
| 29 | ABC transporters_Homo sapiens_hsa02010 | 1.51858233 |
| 30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.51211160 |
| 31 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.46282601 |
| 32 | Retinol metabolism_Homo sapiens_hsa00830 | 1.42649066 |
| 33 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.40225747 |
| 34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.38241845 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.34733187 |
| 36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.26894717 |
| 37 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.26798557 |
| 38 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.25002619 |
| 39 | Viral myocarditis_Homo sapiens_hsa05416 | 1.21326630 |
| 40 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.20963862 |
| 41 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.19257294 |
| 42 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.19226559 |
| 43 | Bile secretion_Homo sapiens_hsa04976 | 1.19121158 |
| 44 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.13365637 |
| 45 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.13183142 |
| 46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.11149863 |
| 47 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.06242285 |
| 48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.05544089 |
| 49 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.05088429 |
| 50 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.02315876 |
| 51 | Platelet activation_Homo sapiens_hsa04611 | 0.95507771 |
| 52 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.95240349 |
| 53 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.94938429 |
| 54 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.94345472 |
| 55 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.93618517 |
| 56 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.91700739 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88694744 |
| 58 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.87890672 |
| 59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.87204802 |
| 60 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.84772015 |
| 61 | Allograft rejection_Homo sapiens_hsa05330 | 0.82319409 |
| 62 | Hepatitis C_Homo sapiens_hsa05160 | 0.81345213 |
| 63 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.79626537 |
| 64 | Leishmaniasis_Homo sapiens_hsa05140 | 0.79574373 |
| 65 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.79236763 |
| 66 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.76086131 |
| 67 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.75282659 |
| 68 | Sulfur relay system_Homo sapiens_hsa04122 | 0.72462521 |
| 69 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.71463869 |
| 70 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.70917893 |
| 71 | Salmonella infection_Homo sapiens_hsa05132 | 0.70654301 |
| 72 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.69136618 |
| 73 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.69000846 |
| 74 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67811326 |
| 75 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.67521654 |
| 76 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.66496313 |
| 77 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.66039230 |
| 78 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.64934569 |
| 79 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.64390121 |
| 80 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.63829103 |
| 81 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.63669117 |
| 82 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.63431587 |
| 83 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.62895227 |
| 84 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.61751517 |
| 85 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.61139035 |
| 86 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.60730082 |
| 87 | Hepatitis B_Homo sapiens_hsa05161 | 0.59991730 |
| 88 | Phagosome_Homo sapiens_hsa04145 | 0.59917028 |
| 89 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.58613030 |
| 90 | Measles_Homo sapiens_hsa05162 | 0.58090017 |
| 91 | Salivary secretion_Homo sapiens_hsa04970 | 0.56638559 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53702062 |
| 93 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.52960742 |
| 94 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.52927564 |
| 95 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.52823552 |
| 96 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.52609075 |
| 97 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.51783901 |
| 98 | Renin secretion_Homo sapiens_hsa04924 | 0.51475093 |
| 99 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.51451903 |
| 100 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.51290403 |
| 101 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.50102447 |
| 102 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.49694478 |
| 103 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.47628443 |
| 104 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.47552259 |
| 105 | Carbon metabolism_Homo sapiens_hsa01200 | 0.46093768 |
| 106 | Pertussis_Homo sapiens_hsa05133 | 0.42855569 |
| 107 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.41958857 |
| 108 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.41444778 |
| 109 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.40263511 |
| 110 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.40111252 |
| 111 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.38117964 |
| 112 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.38009462 |
| 113 | Prion diseases_Homo sapiens_hsa05020 | 0.37963573 |
| 114 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.37543200 |
| 115 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.36867712 |
| 116 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.36470289 |
| 117 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.36462515 |
| 118 | Insulin resistance_Homo sapiens_hsa04931 | 0.36188357 |
| 119 | Lysine degradation_Homo sapiens_hsa00310 | 0.35336664 |
| 120 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34772441 |
| 121 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.33734237 |
| 122 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.33487501 |
| 123 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.33061447 |
| 124 | Tuberculosis_Homo sapiens_hsa05152 | 0.32819426 |
| 125 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.32373375 |
| 126 | Amoebiasis_Homo sapiens_hsa05146 | 0.31487722 |
| 127 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.31343959 |
| 128 | Influenza A_Homo sapiens_hsa05164 | 0.30718840 |
| 129 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.29799164 |
| 130 | Lysosome_Homo sapiens_hsa04142 | 0.29751865 |
| 131 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.29600009 |
| 132 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.29134579 |
| 133 | Olfactory transduction_Homo sapiens_hsa04740 | 0.28407211 |
| 134 | Shigellosis_Homo sapiens_hsa05131 | 0.28290698 |
| 135 | Apoptosis_Homo sapiens_hsa04210 | 0.27381260 |
| 136 | Legionellosis_Homo sapiens_hsa05134 | 0.27180132 |
| 137 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26936183 |
| 138 | HTLV-I infection_Homo sapiens_hsa05166 | 0.26827521 |
| 139 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.26644709 |
| 140 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.25240511 |
| 141 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.24329219 |
| 142 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.23798526 |
| 143 | Other glycan degradation_Homo sapiens_hsa00511 | 0.23644847 |
| 144 | Metabolic pathways_Homo sapiens_hsa01100 | 0.23231086 |
| 145 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.22929832 |
| 146 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.22602428 |

